Pandemic Perspectives: ‘No Pandemic-Driven Slowdown’ According To Simon-Kucher & Partners
Executive Summary
In a discussion with Medtech Insight, partners at Simon-Kucher & Partners explained that the pandemic has, and will continue to, transform both the sales and revenue models of medtech.
You may also be interested in...
ATTD 2021: Despite High Upfront Cost, Medtronic’s 780G Could Offer Cost Savings
In a talk at the 2021 Advanced Technologies & Treatments for Diabetes conference, Medtronic's European director of medical affairs explained how its MiniMed 780G insulin pump can reduce long-term treatment costs for diabetics.
Minute Insight: Virtual Incision Draws In Another $30m With Its Table-Top Surgical Robot
The cash will be used to extend the company’s development runway “well into 2025.”
Snapshot: August Highlights
A selection of articles you may have missed from August 2023, including a breakdown of CEO pay, a discussion on being out and proud in the life sciences sector, and some hopeful discourse on the investment landscape going into 2024.